Gossamer Bio, Inc. (GOSS) NASDAQ

0.34

-0.0054(-1.59%)

Updated at May 13 11:15AM

Currency In USD

Key Executives

Name	Title	Pay	Year Born
Faheem Hasnain	Co-Founder, Chief Executive Officer, President & Chairman	908,449	1958
Christian Waage	Executive Vice President of Technical Operations & Administration	583,156	1967
Robert Smith	Chief Commercial Officer	663,713	1969
Bryan Giraudo	Chief Operating Officer & Chief Financial Officer	676,743	1975
Richard Aranda	Chief Medical Officer	677,492	1960
Robert F. Roscigno	Senior Vice President of Clinical Development of Pulmonary Vascular Disease	0	1966
Conor O'Donovan	Senior Vice President of Regulatory Affairs	0	N/A
Jeff Boerneke	General Counsel & Secretary	0	N/A
Louis K. Cherico	Senior Vice President of Finance & Treasury	0	N/A
Matt Cravets	Senior Vice President of Biometrics	0	N/A
Caryn L. Peterson	Executive Vice President of Regulatory Affairs	0	1959
Jeanine Anthony	Senior Vice President of Marketing	0	N/A
Kelly Dawson	Senior Vice President of Program Team Lead	0	N/A
Deanna Weber	Executive Vice President of Human Resources	0	N/A

Name

Title

Pay

Year Born

Faheem Hasnain

Co-Founder, Chief Executive Officer, President & Chairman

908,449

1958

Christian Waage

Executive Vice President of Technical Operations & Administration

583,156

1967

Robert Smith

Chief Commercial Officer

663,713

1969

Bryan Giraudo

Chief Operating Officer & Chief Financial Officer

676,743

1975

Richard Aranda

Chief Medical Officer

677,492

1960

Robert F. Roscigno

Senior Vice President of Clinical Development of Pulmonary Vascular Disease

1966

Conor O'Donovan

Senior Vice President of Regulatory Affairs

N/A

Jeff Boerneke

General Counsel & Secretary

N/A

Louis K. Cherico

Senior Vice President of Finance & Treasury

N/A

Matt Cravets

Senior Vice President of Biometrics

N/A

Caryn L. Peterson

Executive Vice President of Regulatory Affairs

1959

Jeanine Anthony

Senior Vice President of Marketing

N/A

Kelly Dawson

Senior Vice President of Program Team Lead

N/A

Deanna Weber

Executive Vice President of Human Resources

N/A

Description

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colonystimulating factor 1 receptor, or CSF1R, and c-KIT inhibitor for the treatment of pulmonary arterial hypertension; GB004, a gut-targeted, oral small molecule for the treatment of inflammatory bowel disease; GB5121, an oral, irreversible, covalent, small molecule inhibitor of Bruton's Tyrosine Kinase for the treatment of primary central nervous system lymphoma; and GB7208, an oral, small molecule, BTK inhibitor for the treatment of multiple sclerosis. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds; and Aerpio Pharmaceuticals, Inc. to develop and commercialize GB004 and related compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.